Ctdna monitoring
Clinical trials for Ctdna monitoring explained in plain language.
Never miss a new study
Get alerted when new Ctdna monitoring trials appear
Sign up with your email to follow new studies for Ctdna monitoring, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a platform trial match the right drug combo to each tumor?
Disease control Recruiting nowThis phase I/II platform trial tests several drug combinations, including evorpacept, trastuzumab deruxtecan, zanidatamab, tucatinib, and TTX-MC138, in people with advanced solid tumors, especially metastatic breast cancer. The goal is to find safe and promising regimens that cou…
Matched conditions: CTDNA MONITORING
Phase 1/2 • Sponsor: QuantumLeap Healthcare Collaborative • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Blood test may spare breast cancer patients from chemo
Disease control Recruiting nowThis study tests whether a blood test (ctDNA) can identify women with early-stage, hormone-positive breast cancer who can safely avoid chemotherapy. Instead of chemo, they receive a targeted pill (dalpiciclib) plus hormone therapy before surgery. The goal is to reduce side effect…
Matched conditions: CTDNA MONITORING
Phase 2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Blood test may guide breast cancer therapy, reducing chemo need
Disease control Recruiting nowThis phase 2 trial tests a personalized approach for early-stage, hormone receptor-positive breast cancer. Participants receive a combination of CDK4/6 inhibitors and endocrine therapy before surgery. A blood test (ctDNA) is used to monitor tumor DNA and may help decide if chemot…
Matched conditions: CTDNA MONITORING
Phase 2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC